Particles for inhalation having sustained release properties
Abstract
The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and diagnostic agents to a patient wherein the agent is released in a sustained fashion, and to particles suitable for use in the method. In particular, the invention relates to a method for the pulmonary delivery of a therapeutic, prophylactic or diagnostic agent comprising administering to the respiratory tract of a patient in need of treatment, prophylaxis or diagnosis an effective amount of particles comprising a therapeutic, prophylatic or diagnostic agent or any combination thereof in association with a charged lipid, wherein the charged lipid has an overall net charge which is opposite to that of the agent upon association with the agent. Release of the agent from the administered particles occurs in a sustained fashion.
Term
Term ended
Projected expiry passed 18 December 2021, 4.8 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO0193837A2 | Cites | World Intellectual Property Organization (WIPO) | PA | Search report | 1-10 |
| US2002052310A1 | Cites | United States of America | E | Search report | 1-10 |
| WO9524183A1 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 1-10 |
| WO9632149A1 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 1-10 |
| WO9831346A1 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 1-10 |
32 members in 11 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 752109 | United States of America | – | |
| 75210900 | United States of America | A | |
| 75210900 | United States of America | A | |
| 01991253 | European Patent Office (EPO) | A | |
| 01991253 | European Patent Office (EPO) | A | |
| 01991253 | – | – | – |
| 752109 | – | – | – |
| EP20010991253 | – | – | – |
| US20000752109 | – | – | – |
Members32
| Document | Office | Kind | |
|---|---|---|---|
| CA2433335A1 | Canada | A1 | |
| WO02053190A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO02053190A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2002141946A1 | United States of America | A1 | |
| CA2449439A1 | Canada | A1 | |
| WO03000202A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO02053190A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO02053190A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2003118513A1 | United States of America | A1 | |
| US2003125236A1 | United States of America | A1 | |
| WO03000202A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1345629A2 | European Patent Office (EPO) | A2 | |
| MXPA03011861A | Mexico | A | |
| EP1404299A2 | European Patent Office (EPO) | A2 | |
| IL158987A0 | Israel | A0 | |
| CN1518441A | China | A | |
| JP2005500309A | Japan | A | |
| JP2005504715A | Japan | A | |
| PL367399A1 | Poland | A1 | |
| AU2002230993B2 | Australia | B2 | |
| US7048908B2 | United States of America | B2 | |
| JP2006249099A | Japan | A | |
| AU2002350606B2 | Australia | B2 | |
| NZ530123A | New Zealand | A | |
| EP1797902A2 | European Patent Office (EPO) | A2 | |
| EP1797902A3This record | European Patent Office (EPO) | A3 | |
| US2008039366A1 | United States of America | A1 | |
| JP4067047B2 | Japan | B2 | |
| US2008226730A1 | United States of America | A1 | |
| US2008227690A1 | United States of America | A1 | |
| US2010026235A1 | United States of America | A1 | |
| CA2433335C | Canada | C |
12 legal events, as 2 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Applications withdrawn, deemed to be withdrawn, or refused after publication in hong kongWithdrawnWD | WD | HK | |
| Application deemed to be withdrawnWithdrawn18D | 18D | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA | STAA | EP | |
| Designation fees paidAKX | AKX | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Requests to designate patent in hong kongDE | DE | HK | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1797902
- Publication, DOCDB
- 1797902
- Publication, EPODOC
- EP1797902
- Application
- 6076387
- Application, DOCDB
- 06076387
- Application, EPODOC
- EP20060076387
Titles3
- German
- Inhalationspartikel mit verzögerter Freigabe
- English
- Particles for inhalation having sustained release properties
- French
- Particules à libération prolongée destinées à être inhalées
Classification
- CPC, 6
- A61K9/0075
- A61K9/1617
- A61K38/28
- A61K47/544
- A61P3/10
- A61P43/00
- IPC, 12
- A61K47 48
- A61K9 14
- A61K9 16
- A61K31 137
- A61K31 566
- A61K38 28
- A61K38 30
- A61K47 02
- A61K47 12
- A61K47 18
- A61P3 10
- A61P43 00
Designated states1
- Contracting states, 1
- Türkiye